1. Home
  2. FTLF vs KPTI Comparison

FTLF vs KPTI Comparison

Compare FTLF & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FitLife Brands Inc.

FTLF

FitLife Brands Inc.

HOLD

Current Price

$15.83

Market Cap

154.6M

Sector

Health Care

ML Signal

HOLD

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$7.00

Market Cap

148.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTLF
KPTI
Founded
2005
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
154.6M
148.0M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
FTLF
KPTI
Price
$15.83
$7.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$23.00
$22.17
AVG Volume (30 Days)
17.2K
452.5K
Earning Date
11-13-2025
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.68
N/A
Revenue
$70,561,000.00
$142,530,000.00
Revenue This Year
$32.74
$3.82
Revenue Next Year
$50.36
N/A
P/E Ratio
$23.18
N/A
Revenue Growth
12.44
N/A
52 Week Low
$9.83
$3.51
52 Week High
$20.98
$10.75

Technical Indicators

Market Signals
Indicator
FTLF
KPTI
Relative Strength Index (RSI) 45.95 50.78
Support Level $15.01 $6.36
Resistance Level $16.90 $7.09
Average True Range (ATR) 0.51 0.69
MACD 0.11 -0.08
Stochastic Oscillator 49.21 35.77

Price Performance

Historical Comparison
FTLF
KPTI

About FTLF FitLife Brands Inc.

FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Isatori, and Biogenetic laboratories brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

Share on Social Networks: